Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: A case report

Journal of Clinical Psychiatry

Volumn 65, Issue 9, 2004, Pages 1286-1287

  Anghelescu, Ion ^a   Wolf, Jürgen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; PROLACTIN; QUINOLONE DERIVATIVE; THIAZOLE DERIVATIVE; ZIPRASIDONE;

ADULT; AMBULATORY CARE; BLOOD; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; HYPERPROLACTINEMIA; LETTER; PARANOID SCHIZOPHRENIA; PSYCHOLOGICAL ASPECT; PSYCHOSEXUAL DISORDER;

ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; PIPERAZINES; PROLACTIN; QUINOLONES; SCHIZOPHRENIA, PARANOID; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; THIAZOLES;

EID: 5444252294     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0918f     Document Type: Letter

References (9)

1. Goodnick PJ, Rodriguez L, Santana O. Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother 2002;3:1381-1391 (Pubitemid 35189526)
2. Maguire GA. Prolactin elevation with antipsychotic medications: mechanism of action and clinical consequences. J Clin Psychiatry 2002;63(suppl 4):56-62 (Pubitemid 34242111)
3. Stimmel GL, Gutierrez MA, Lee V. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clin Ther 2002;1:21-37
4. 2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Brain Res Mol Brain Res 1998;55:285-292 (Pubitemid 28248045)
5. Compton MT, Miller AH. Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull 2002;36:143-164
6. Kay SR, Opler LA, Fiszbein A. The Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health System; 1986
7. Petty RG. Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 1999:S67-S73 (Pubitemid 29133027)
8. Mallikaarjun S, Salazar DE, Bramer SL. Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers. J Clin Pharmacol 2004:44:179-187 (Pubitemid 38114317)
9. Gründer G, Carlsson A, Wong DF. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry 2003;60:974-977 (Pubitemid 37222078)